Insider · CIK 0001652410

Hecht Beth

Reports to the SEC for 5 companies · CHICAGO, IL

sec.gov

Transactions

Companies

Filings

CIK

0001652410

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-01	XERSXeris Biopharma Holdings, Inc.S Sale	See Remarks	SSale	−16.7K sh	$9.41	−$157K	1,111,130
2026-09-01	XERSXeris Biopharma Holdings, Inc.S Sale	See Remarks	SSale	−16.7K sh	$8.49	−$141K	1,127,796
2026-08-03	XERSXeris Biopharma Holdings, Inc.S Sale	See Remarks	SSale	−16.7K sh	$8.01	−$134K	1,144,462
2026-07-01	XERSXeris Biopharma Holdings, Inc.S Sale	See Remarks	SSale	−16.7K sh	$8.03	−$134K	1,161,128
2026-06-01	XERSXeris Biopharma Holdings, Inc.S Sale	See Remarks	SSale	−16.7K sh	$6.06	−$101K	1,176,506
2026-05-01	XERSXeris Biopharma Holdings, Inc.S Sale	See Remarks	SSale	−16.7K sh	$6.23	−$104K	1,193,173
2026-04-01	XERSXeris Biopharma Holdings, Inc.S Sale	See Remarks	SSale	−16.7K sh	$5.99	−$99.9K	1,209,840
2026-03-02	XERSXeris Biopharma Holdings, Inc.S Sale	See Remarks	SSale	−16.6K sh	$6.24	−$103K	1,226,607
2026-03-02	XERSXeris Biopharma Holdings, Inc.S Sale	See Remarks	SSale	−100 sh	$7.06	−$706	1,226,507
2026-02-02	XERSXeris Biopharma Holdings, Inc.S Sale	See Remarks	SSale	−16.7K sh	$7.45	−$124K	1,243,174
2026-01-31	XERSXeris Biopharma Holdings, Inc.F Tax Payment	See Remarks	FTax Payment	−98.4K sh	$7.36	−$724K	1,331,021
2026-01-31	XERSXeris Biopharma Holdings, Inc.F Tax Payment	See Remarks	FTax Payment	−24.3K sh	$7.36	−$179K	1,259,841
2026-01-31	XERSXeris Biopharma Holdings, Inc.F Tax Payment	See Remarks	FTax Payment	−46.9K sh	$7.36	−$345K	1,284,107
2026-01-30	XERSXeris Biopharma Holdings, Inc.A Award	See Remarks	AAward	+121K sh	—	—	1,429,396
2026-01-30	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+162K sh	—	—	162,162
2026-01-02	XERSXeris Biopharma Holdings, Inc.S Sale	See Remarks	SSale	−16.7K sh	$7.43	−$124K	1,308,103
2025-12-01	XERSXeris Biopharma Holdings, Inc.S Sale	See Remarks	SSale	−16.7K sh	$7.01	−$117K	1,320,176
2025-11-11	XERSXeris Biopharma Holdings, Inc.S Sale	See Remarks	SSale	−16.7K sh	$7.40	−$123K	1,336,843
2025-03-20	XERSXeris Biopharma Holdings, Inc.S Sale	See Remarks	SSale	−40K sh	$5.43	−$217K	1,353,510
2025-01-31	XERSXeris Biopharma Holdings, Inc.F Tax Payment	See Remarks	FTax Payment	−98.4K sh	$3.56	−$350K	1,208,510
2025-01-31	XERSXeris Biopharma Holdings, Inc.A Award	See Remarks	AAward	+185K sh	—	—	1,393,510
2025-01-31	XERSXeris Biopharma Holdings, Inc. · Stock Appreciation RightA Award	See Remarks	AAward	+300K sh	—	—	300,000
2025-01-31	XERSXeris Biopharma Holdings, Inc.F Tax Payment	See Remarks	FTax Payment	−45.9K sh	$3.56	−$163K	1,306,885
2025-01-03	XERSXeris Biopharma Holdings, Inc.F Tax Payment	See Remarks	FTax Payment	−32K sh	$3.61	−$116K	1,352,794
2024-01-31	XERSXeris Biopharma Holdings, Inc.F Tax Payment	See Remarks	FTax Payment	−45.9K sh	$2.46	−$113K	1,380,802
2024-01-31	XERSXeris Biopharma Holdings, Inc.A Award	See Remarks	AAward	+750K sh	—	—	1,554,968
2024-01-29	XERSXeris Biopharma Holdings, Inc.F Tax Payment	See Remarks	FTax Payment	−19.7K sh	$2.66	−$52.3K	1,426,711
2024-01-03	XERSXeris Biopharma Holdings, Inc.F Tax Payment	See Remarks	FTax Payment	−33.5K sh	$2.24	−$75K	1,446,386
2023-06-15	ITRMIterum Therapeutics plc · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−15.9K sh	—	—	0
2023-06-15	ITRMIterum Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+15.9K sh	—	—	18,839
2023-01-31	XERSXeris Biopharma Holdings, Inc.A Award	See Remarks	AAward	+350K sh	—	—	797,758
2023-01-31	XERSXeris Biopharma Holdings, Inc.F Tax Payment	See Remarks	FTax Payment	−5,784 sh	$1.24	−$7,172.16	1,479,874
2023-01-29	XERSXeris Biopharma Holdings, Inc.F Tax Payment	See Remarks	FTax Payment	−21.2K sh	$1.26	−$26.7K	1,485,658
2023-01-03	XERSXeris Biopharma Holdings, Inc.F Tax Payment	See Remarks	FTax Payment	−33.5K sh	$1.12	−$37.5K	1,506,835
2022-06-23	ITRMIterum Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+36.8K sh	—	—	44,805
2022-06-23	ITRMIterum Therapeutics plc · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−36.8K sh	—	—	0
2022-06-15	ITRMIterum Therapeutics plc · Restricted Share UnitsA Award	Director	AAward	+238K sh	$0.01	+$2,377.95	237,795
2022-03-18	ITRMIterum Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+7,642 sh	—	—	8,007
2022-03-18	ITRMIterum Therapeutics plc · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−7,642 sh	—	—	0
2022-01-31	XERSXeris Biopharma Holdings, Inc.F Tax Payment	See Remarks	FTax Payment	−4,448 sh	$2.11	−$9,385.28	1,540,323
2022-01-29	XERSXeris Biopharma Holdings, Inc.F Tax Payment	See Remarks	FTax Payment	−14K sh	$2.11	−$29.6K	1,544,771
2022-01-03	XERSXeris Biopharma Holdings, Inc.A Award	See Remarks	AAward	+225K sh	—	—	436,821
2021-10-05	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+30.9K sh	—	—	30,879
2021-10-05	XERIS PHARMACEUTICALS INCD Disposition to Issuer	See Remarks	DDisposition to Issuer	−26.4K sh	—	—	180,000
2021-10-05	XERIS PHARMACEUTICALS INCD Disposition to Issuer	See Remarks	DDisposition to Issuer	−180K sh	—	—	0
2021-10-05	XERIS PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−30.9K sh	—	—	0
2021-10-05	XERIS PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−65.3K sh	—	—	0
2021-10-05	XERIS PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−3,826 sh	—	—	0
2021-10-05	XERIS PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−32.5K sh	—	—	0
2021-10-05	XERIS PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−150K sh	—	—	0

Recent filings

Accepted (ET)
Oct 24
Hecht Beth0001867096-26-000084
SEC(opens sec.gov)
Sep 14
Hecht Beth0001652410-26-000018
SEC(opens sec.gov)
Aug 44
Hecht Beth0001652410-26-000016
SEC(opens sec.gov)
Jul 24
Hecht Beth0001652410-26-000014
SEC(opens sec.gov)
Jun 24
Hecht Beth0001652410-26-000012
SEC(opens sec.gov)
May 14
Hecht Beth0001652410-26-000010
SEC(opens sec.gov)
Apr 34
Hecht Beth0001652410-26-000008
SEC(opens sec.gov)
Mar 44
Hecht Beth0001652410-26-000006
SEC(opens sec.gov)
Feb 24
Hecht Beth0001652410-26-000004
SEC(opens sec.gov)
Jan 54
Hecht Beth0001652410-26-000002
SEC(opens sec.gov)
Dec 24
Hecht Beth0001652410-25-000005
SEC(opens sec.gov)
Nov 134
Hecht Beth0001652410-25-000003
SEC(opens sec.gov)
Mar 214
Hecht Beth0001867096-25-000047
SEC(opens sec.gov)
Feb 34
Hecht Beth0001867096-25-000025
SEC(opens sec.gov)

Companies

Address

C/O XERIS BIOPHARMA HOLDINGS, INC. 1375 WEST FULTON STREET, SUITE 1300

CHICAGO, IL, 60607